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a  b  s  t  r  a  c  t
Caffeine  is  consumed  by over  80%  of  U.S.  adults.  This  review  examines  the  effects  caffeine  has  on  cognitive
and physical  function,  since  most  real-world  activities  require  complex  decision  making,  motor  process-
ing  and  movement.  Caffeine  exerts  its effects  by  blocking  adenosine  receptors.  Following  low  (∼40  mg  or
∼0.5 mg  kg−1) to moderate  (∼300  mg or 4 mg  kg−1)  caffeine  doses,  alertness,  vigilance,  attention,  reaction
time  and attention  improve,  but  less  consistent  effects  are  observed  on  memory  and higher-order  exec-
utive  function,  such  as judgment  and  decision  making.  Effects  on  physical  performance  on a vast  array
of  physical  performance  metrics  such  as  time-to-exhaustion,  time-trial,  muscle  strength  and  endurance,
and high-intensity  sprints  typical  of  team  sports  are  evident  following  doses  that  exceed  about  200 mg
(∼3  mg  kg−1).  Many  occupations,  including  military,  ﬁrst  responders,  transport  workers  and  factory  shift
workers,  require  optimal  physical  and  cognitive  function  to  ensure  success,  workplace  safety  and  pro-eaction time
ime-to-exhaustion
ime-trial
uscle strength and power
igh-intensity sprints
ductivity.  In  these  circumstances,  that  may  include  restricted  sleep,  repeated  administration  of caffeine
is an  effective  strategy  to maintain  physical  and  cognitive  capabilities.
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. Introduction
Caffeine is one of the most widely consumed foods and sup-
lements in the world. In the U.S., approximately 85% of adults
onsume caffeine (Fray et al., 2005; Fulgoni et al., 2015). Most
affeine is consumed as coffee (Barone and Roberts, 1996) but
affeine is also present in numerous foods, drugs and beverages
Table 1). Caffeine is psychoactive in doses found in single servings
f many beverages (Lieberman et al., 1987a; Smith et al., 1999) and
s the active ingredient in a relatively new product − energy drinks
McLellan and Lieberman, 2012). At the request of the US Food and
rug Administration, the Institute of Medicine recently convened
 workshop to review the safe levels of caffeine consumption in
any of the products identiﬁed in Table 1 (Institute of Medicine,
014). A wide variety of beneﬁts and risks have been attributed to
affeine, but it is generally agreed that for healthy adults, daily con-
umption of up to 400 mg  (∼5.5 mg  kg−1 for a 75 kg individual) of
affeine does not present a health risk (Doepker et al., 2016; Higdon
nd Frei, 2006; Nawrot et al., 2003).
Numerous reviews have addressed the effects of caffeine on
ither physical or cognitive performance alone (Burke, 2008; Davis
nd Green, 2009; Graham, 2001; Lieberman et al., 2010; Shearer
nd Graham, 2014; Spriet, 2014). However, since Weiss and Laties
id so in 1962 there have been only a few attempts to summarize
affeine’s effects on both physical and cognitive function (Goldstein
t al., 2010; Rogers and Dinges, 2005; Sökmen et al., 2008) and
hese latter reviews focussed on issues of interest to the sporting
ommunity. Nevertheless, it is clear that there are doses of caffeine
vailable in foods and beverages that raise plasma concentration
o levels which block adenosine receptors (Fredholm, 1979, 1995;
redholm et al., 1999), and exert central nervous system (CNS)
ffects, to a degree that impacts both cognitive and physical func-
ion. It is also evident that there are many occupational settings, as
ell as sporting and leisure activities, where optimal physical and
ognitive function is critical for performance success, safety and
roductivity. But what is the evidence-base that might support or
efute the use of caffeine in these sporting and occupational set-
ings, and is there a dose of the drug and timing of ingestion that
ill positively affect both cognitive and physical function or are the
otential effects mutually independent or even antagonistic? These
ssues need to be carefully considered since rarely do the physical
emands in sport or occupation occur in isolation from complex
ecision making, motor processing and movement. After brieﬂy
iscussing the pharmacology and mechanisms of action of the drug,
he effects of caffeine on various aspects of cognitive function will
e addressed. Due to the immense literature on the behavioral
ffects of caffeine we have restricted our review to key aspects of
ognitive function, especially those that may  be related to occu-
ational performance. This will be followed by a review of studies
ddressing various aspects of physical performance and then stud-
es that have addressed the effects of caffeine on both physical and
ognitive performance in various occupational settings. The review .  . .  . . .  .  .  . . . . . .  . .  .  . . .  .  .  . . . .  . . .  . . . . . . .  . . . . . . .  . . .  . . . .  . . . . .  .  . . . .  . .  .  .  .  .  .  . .  .  . . .  . . 307
includes an assessment of peer-reviewed publications and reports
available through end Spring 2016.
2. Pharmacology, metabolism and mechanisms of action
Caffeine (1,3,7-trimethylxanthine) is formed when three methyl
groups are substituted on the parent compound xanthine. Fol-
lowing ingestion, caffeine is rapidly absorbed reaching peak
concentrations in the circulation within an hour (Blanchard and
Sawers, 1983; Robertson et al., 1981), although there is consid-
erable individual variation (Desbrow et al., 2009; Skinner et al.,
2013). In addition, absorption is slower when caffeine is consumed
with a meal (Dews, 1982; Fleischer et al., 1999), but absorption
is faster when it is provided in gum. Chewing caffeine-containing
gum allows for rapid absorption through buccal tissue of the mouth
(Kamimori et al., 2002). Caffeine is rapidly distributed to all tissues
and readily crosses the blood-brain barrier to exert its effects. The
half-life of caffeine in the circulation is normally 3–5 h (Fredholm,
1995), thus it interacts with many tissues for prolonged periods of
time. Furthermore, smoking, certain dietary choices, liver disease,
pregnancy or the use of oral contraceptives can alter the half-life
of caffeine (Collomp et al., 1991; Curatolo and Robertson, 1983;
Denaro et al., 1990; Peterson et al., 2006, 2009).
Caffeine is structurally similar to adenosine, a neuromodu-
lator, whose formation is dependent on the relative rates of
ATP breakdown and synthesis (Fredholm, 1995). Four distinct G-
protein-coupled adenosine receptors, A1, A2a, A2b and A3, have been
identiﬁed (Fredholm et al., 1994), each with a unique tissue distri-
bution and pharmacological proﬁle (Fisone et al., 2004; Landolt,
2008). Adenosine receptor density and sensitivity can vary among
individuals (Martin et al., 2006), and receptors are up-regulated
as caffeine intake increases (Varani et al., 2000). Caffeine’s mech-
anism of action has been deﬁnitively established as explained by
Fig. 1. Previously, caffeine’s effects were thought to be due to inhi-
bition of phosphodiesterase or by promoting intracellular Ca2+
release, but these effects occur with very high, non-physiological
concentrations of caffeine. It is now known that the micromo-
lar tissue concentrations of caffeine that result from ingestion of
low to moderate doses of caffeine block A1 and A2a adenosine
receptors (Fredholm, 1979). Nevertheless, as will be reviewed in
Section 4.2, there is some evidence that the effects of caffeine on
physical performance could be related to the release of calcium
from the sarcoplasmic reticulum and inhibition of its reuptake,
which subsequently increases nitric oxide via the activation of
endothelial nitric oxide synthase (see Cappelletti et al., 2015). These
actions may  be associated with changes in neuromuscular function
and increased contractile force in skeletal muscles that could be
ergogenic (Tarnopolsky, 2008).
While both the A1 and A2a adenosine receptors are believed to be
responsible for the behavioral effects of caffeine, their relative con-
tributions have not been established. Both receptor subtypes are
expressed in the brain and periphery. High levels of A1 receptors are
found in the hippocampus, cortex, cerebellum and hypothalamus
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Table  1
Estimated caffeine content of beverages, foods and dietary supplements (Lieberman et al., 2010; McLellan and Lieberman, 2012).
Item Caffeine content (mg/100 mL)  Serving size (mL) Caffeine content (mg/serving)
Coffee
Drip method 60–100 150 90–150
Instant 27–72 150 40–108
Decaffeinated 1–3 150 2–5
Tea
1-min  brew 6–22 150 9–33
5-min  brew 13–33 150 20–50
Iced  Tea 6–10 350 22–36
Chocolate Products
Hot cocoa 1–5 175 2–8
Chocolate milk 1–3 235 2–7
Milk  chocolate 3–50 30 1–15
Baking chocolate 115 30 35
Cola  Beverages
Coca-Cola® 10 350 35
Diet  Coke® 13 350 47
Pepsi® 11 350 38
Diet  Pepsi® 10 350 36
Other  soft drinks
Dr. Pepper® 11 350 40
Mountain Dew® 16 350 55
Barq’s® Root Beer 7 350 23
Energy Drinks
Amp® 30 235 71
Cocaine® 120 235 280
Monster® 34 235 80
Red  Bull® 34 235 80
Rockstar® 34 235 80
Energy Shots
5-h Energy® 333 60 200
10-h  Time Release® 740 57 422
Over-the-counter Medication
Anacin (1 tablet) – − 32



























cMidol  (1 pill) – 
NoDoz  (1 tablet) – 
 oz = 29.56 mL.
Landolt, 2008). The A2a subtype is present in regions of the brain
uch as the striatum, nucleus accumbens and olfactory tubercle,
nd are heavily innervated by dopamine-containing ﬁbers (Nehlig,
999). Adenosine appears to inhibit the release of many neuro-
ransmitters in the central nervous system (Nehlig et al., 1992). In
nimal models, adenosine A1 receptor agonists have been shown
o inhibit release of glutamate (Ciruela et al., 2006; Flagmeyer
t al., 1997; Marchi et al., 2002; Yang et al., 2013), serotonin
Okada et al., 1999), acetylcholine (Brown et al., 1990; Rainnie et al.,
994), noradrenaline (Fredholm, 1979) and dopamine (as discussed
elow). Adenosine receptor antagonists, such as caffeine, therefore
ould promote the release of these various neurotransmitters. For
xample, caffeine has been linked to the modulation of aggres-
ive behavior through its inhibitory effects on serotonin release
Mahoney et al., 2011), and methylxanthines, such as theophylline
nd caffeine, have been implicated in lowering the epileptic seizure
hreshold through antagonism of adenosine on glutamatergic neu-
ons (Boison, 2011; Dunwiddie, 1980; Fukuda et al., 2010).
As reviewed elsewhere (Ferré, 2010, 2016; Fuxe et al., 2005),
denosine A1 and A2a receptors form functional and pharmaco-
ogically active heteromers with dopamine D1 and D2 receptors in
ifferent regions of the brain. For example, by blocking A2a recep-
ors in the striatum caffeine antagonizes adenosine’s effects and
ndirectly promotes dopamine’s stimulatory effects on psychomo-
or activity, by acting on its D2 receptor. Genetic polymorphisms of
he A2a and D2 receptor in humans have also been associated with
affeine’s effects on anxiety (Childs et al., 2008). Caffeine’s effects− 60
− 200
on arousal, especially during prolonged periods of wakefulness,
appear to involve both direct modulation of adenosine A1 receptors
in the basal forebrain as well as indirect effects on the noradrenergic
and hypothalamic histaminergic and orexinergic systems, through
modulation of both A1 and A2a receptors (Ferré, 2010). Neurochem-
ical models have been proposed to explain the ability of adenosine
A1 and A2a receptor antagonists to increase arousal during periods
of sleep loss for treatment of daytime sleepiness and hypokine-
sia during Parkinson’s disease (Sil’kis, 2009, 2014). According to
these models, activation of adenosine A1 receptors should induce
long-term depression of excitatory inputs to striatonigral neurons,
whereas A2a receptor activation can induce long-term potentia-
tion of inhibitory inputs to striatopallidal neurons. Therefore, the
use of caffeine as an adenosine receptor antagonist can, in the-
ory, promote excitation of striatonigral neuronal projections and
reduce inhibitory signals to striatopallidal neurons. Both of these
responses, therefore, are likely involved in the increase in arousal
and enhanced psychomotor activity that follows ingestion of caf-
feine during sleep loss.
Single nucleotide polymorphisms of the ADORA2A gene, which
codes for the A2a receptor, have been identiﬁed as thymine
and cytosine substitutions at position 1083. Between 15–20%
of individuals are homozygous for thymine, whereas about 35%
are homozygous for cytosine (Childs et al., 2008). These poly-
morphisms appear to inﬂuence an individual’s response to the
stimulant effects of caffeine (Bodenmann et al., 2012; Yang et al.,
2010).
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Fig. 1. Concentration-effect curves for caffeine at various potential sites of action.
Caffeine markedly affects A1 and A2a receptors at low micromolar concentrations.






























dpproximate caffeine concentrations resulting from a single cup of coffee and toxic
oses of caffeine are indicated. (Modiﬁed from Fredholm (1995) with permission
rom Elsevier.).
In summary, circulating levels of caffeine resulting from inges-
ion of caffeine-containing beverages or food products result in
he antagonism of adenosine A1 and A2a receptors in the CNS and
eripheral tissues. Clearance of caffeine is inﬂuenced by diet and
enetics. Lifestyle and genetics affect adenosine receptor number
nd sensitivity and can impact how an individual responds to a
iven dose of caffeine.
. Effects on cognitive performance
For centuries, caffeine, often in the form of coffee or tea, has been
 popular means to enhance various aspects of mental or cogni-
ive functions (Snel and Lorist, 2011). Although there is widespread
cientiﬁc agreement about caffeine’s behavioral effects, certain
etails regarding speciﬁc functional aspects remain controversial
Smith, 2011). For instance, there is general consensus that caffeine
mproves “lower” cognitive functions such as simple reaction time,
hereas caffeine’s effects on “higher” cognitive functions such as
roblem solving and decision making are often debated (Kosslyn
nd Smith, 2001). In part, this is because there are fewer pub-
ished studies on higher-order cognitive function, and those that are
vailable vary greatly with respect to methods employed (Brunyé
t al., 2010a). The scientiﬁc consensus regarding basic cognitive
unctions is that caffeine in doses from 32 to 300 mg  (or roughly
.5–4 mg  kg−1 for a 75 kg individual) enhance fundamental aspects
f cognitive performance, such as attention, vigilance, and reaction
ime (Lorist and Snel, 2008; Nehlig, 2010; Snel et al., 2004). How-
ver, low and moderate doses of caffeine have not been shown to
lter sensory functions (i.e., vision or hearing) to a signiﬁcant degree
Lieberman, 1992).
Caffeine increases arousal in a dose-dependent manner; low
oses can improve hedonic tone and may  reduce anxiety, whilehavioral Reviews 71 (2016) 294–312 297
high doses increase tension and symptoms of anxiety, nervous-
ness and jitteriness (Stafford et al., 2007). How caffeine affects
performance depends in part on the arousal level of the individu-
als under investigation, especially the extent to which subjects are
sleep-deprived or fatigued versus well-rested. Nehlig (2010) sug-
gested the classic inverted U-shaped arousal-performance function
can partly explain the extent to which caffeine either improves or
degrades function. According to the Yerkes-Dodson law (Yerkes and
Dodson, 1908), there is an empirical relationship between arousal
and performance, such that low arousal is associated with poor
performance whereas increased physiological or mental arousal
is associated with improved performance, but only up to a point.
When arousal level becomes too high, performance decreases.
Thus, a subject’s pre-dose arousal level before consuming caffeine
will inﬂuence the effects observed (Wood et al., 2014). Adminis-
tration of a large dose of caffeine to an individual who is severely
fatigued likely will improve performance because in this case, caf-
feine promotes a favorable arousal level (i.e., caffeine advances
the subject’s arousal into the middle range of the Yerkes-Dodson
curve). Conversely, giving the same dose to someone who already
is well-rested and highly aroused may  degrade rather than improve
performance because in this case, caffeine produces a state of over-
arousal, which according to the Yerkes-Dodson law, will degrade
cognition. Under normal day-to-day circumstances, there is evi-
dence to suggest people use caffeine to achieve a self-perceived,
peak state of arousal, as they modulate their caffeine usage until
they reach their self-selected optimal level of arousal and cog-
nitive performance (in accordance with the Yerkes-Dodson law)
(Harvanko et al., 2015). In studies of caffeine where the doses under
investigation are properly matched to the individual’s arousal state,
beneﬁcial effects are likely to be observed.
Although the curvilinear relationship between caffeine-induced
activation and performance may  be contested, as well as the
Yerkes-Dodson law itself, there is considerable support for both in
many studies over the past 100 years (for example, see Anderson,
1994 and Watters et al., 1997). In any case a comprehensive exam-
ination of the validity of the Yerkes-Dotson law is well beyond
the scope of this review. However, it should be noted the pre-
cise effects of caffeine or any other psychostimulants on behavior
may  be differentially inﬂuenced by the difﬁculty of the task under
investigation (Diamond, 2005), individual differences in caffeine
sensitivity (Renda et al., 2015), gender or body-weight differ-
ences (Wood et al., 2014), the motivational or emotional state of
the volunteers (Diamond et al., 2007), impulsivity and sociability
(Anderson, 1994), and/or other factors. Thus, while the dose-related
impact of caffeine is generally curvilinear with the optimal dosage
residing near the middle of the arousal/activation curve, it would
be an oversimpliﬁcation to assume that caffeine’s effects pre-
cisely follow an inverted U-shaped function across all behaviors,
emotional/motivational states, personality types, and unique indi-
viduals.
Given the qualiﬁcations noted above, it is generally the case that
caffeine in doses up to approximately 300 mg (4 mg·kg−1) enhances
performance with minimal side effects across a wide variety of
cognitive functions, often by preventing decrements in alertness
and attention arising from suboptimal arousal (Lieberman et al.,
2002). As will be discussed below and summarized in Supplemen-
tary Table 1, caffeine consistently improves mood, reaction time
and vigilance when alertness is reduced, and given that some basic
level of arousal is essential for the performance of any task, it
is logical that caffeine is particularly useful in fatiguing circum-
stances. Rested (non-sleep-deprived) individuals engaged in long,
monotonous activities such as military sentry duty or lengthy peri-
ods of highway driving can experience substantial performance
beneﬁts from 200-mg doses of caffeine (Carvey et al., 2012; Reyner
and Horne, 1997, 2000) and for sleep-deprived individuals doses
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anging from 200 to 600 mg  (∼2.5–8 mg  kg−1) are helpful (Carvey
t al., 2012; Lieberman et al., 2002; Penetar et al., 1993; Smith,
005; Wesensten et al., 2002). Thus, the direct impact of sleep
oss or the monotonous contextual factors shift alertness/activation
oward the low end of the U-shaped arousal continuum where caf-
eine’s energizing properties serve to prevent the manifestation of
nderlying physiological drowsiness.
.1. Reaction time
Individual studies have demonstrated beneﬁcial effects of caf-
eine on simple and/or visual-recognition reaction time (RT) (Balkin
t al., 2004; Clubley et al., 1979; Kahathuduwa et al., 2016;
ieberman et al., 1987a; Lorist et al., 1994; Wesensten et al., 2002,
004) and choice reaction time (Lieberman et al., 1987a); and
eviews of the literature agree that caffeine improves reaction time
Lieberman et al., 2010; Nehlig, 2010; Smith, 2002). When admin-
stered in doses ranging from 12.5 to 400 mg  (∼0.2–5.5 mg  kg−1)
o both rested and sleep-deprived individuals caffeine enhances
eaction time (Einother and Giesbrecht, 2013). A few studies fail to
upport these positive results (Kuznicki and Turner, 1986; Lane,
997), but such discrepancies appear attributable to differences
n study populations (habitual versus non-habitual caffeine users,
affeine-deprived versus non-caffeine-deprived subjects) and/or
ivergent test methods and/or dosing levels (Lieberman, 1992;
eiss and Laties, 1962) rather than differential effects of caffeine
tself.
.2. Vigilance
The impact of caffeine on tasks requiring vigilance, the ability to
ustain performance on lengthy, boring or tedious tasks, is clear. In
act, it appears that sustained tests of vigilance or tasks with sub-
tantial embedded vigilance components are the most sensitive to
he behavioral effects of caffeine in rested individuals (Lieberman
t al., 2010) as doses in the 200 mg  (∼2.5 mg  kg−1) range improve
erformance for several hours. Similar effects (with 200–300 mg,
r 2.5–4.0 mg  kg−1, doses) also are seen in persons deprived of
leep continuously for as long as 3 days (Lieberman et al., 2002). In
on-sleep deprived individuals, doses ranging from 32 to 256 mg
∼0.5–3.5 mg  kg−1) of caffeine have been shown to increase the
umber of signal tones detected on the 1-h-long Wilkinson audi-
ory vigilance test without altering the number of false alarms
Lieberman et al., 1987a,b). Rosenthal et al. (1991) found that
wice-daily administrations of 75 and 150 mg  (1–2 mg·kg−1) doses
f caffeine improved reaction time in an auditory vigilance task
oth in sleep-restricted and rested subjects, while performance on
 shorter (15 min) divided attention task was unchanged. Visual
igilance detection rates improved in non-sleep-deprived individ-
als who were tested after administration of caffeine in doses of
2–256 mg  (Amendola et al., 1998). Fine et al. (1994) conﬁrmed and
xtended these ﬁndings by demonstrating that caffeine affected
isual vigilance in rested young males. In that investigation, a
00 mg  dose (∼2.5 mg  kg−1) of caffeine signiﬁcantly and consis-
ently improved both number of stimulus detections and reaction
imes to stimuli in comparison to placebo across 12, 10-min test
locks for a total of 2 h of testing (see Fig. 2). Lanini et al. (2016)
eported that personalized individual caffeine doses designed to
atch participants’ habitual breakfast-time caffeine intake (doses
anged from 25 to 300 mg  or ∼ 0.3 to 4 mg·kg−1) improved sim-
le and sustained attention on the psychomotor vigilance task. In
his study, caffeine signiﬁcantly reduced mean reaction time and
ed to less variable response times from the beginning to the end
f the 10 min  task. Reyner and Horne (1997, 2000) reported that a
00 mg  dose of caffeine signiﬁcantly improved the lane-trackingFig. 2. Effect of 200 mg caffeine versus placebo on reaction time (A) and stimulus
detection (B) in a visual vigilance task. Redrawn from Fine et al. (1994).
performance of sleep-restricted subjects during monotonous, 2-
h, afternoon and early-morning drives in an automobile driving
simulator. In a separate “real-world” relevant study with Air Force
pilots, Doan et al. (2006) found that two  200-mg doses of caffeine
(spaced 4 h apart) maintained several aspects of cognitive perfor-
mance including vigilance over 9 h of overnight testing simulating
a reconnaissance mission in a U-2 aircraft.
In summary, caffeine’s effects on vigilance are very consistent
from study to study. Even small doses (32 mg  or ∼0.5 mg  kg−1) can
have beneﬁcial effects, often regardless of whether subjects are
well-rested or not (Lieberman, 1992; Nehlig et al., 1992). Reviews
have noted that caffeine reliably enhances vigilance independent
of gender, age, and the normal daily intake levels (at least within
the 0–400 mg  range or up to about 5.5 mg  kg−1) of the individuals
studied (Lieberman, 1992; Smith, 2002).
3.3. Attention
Attention is the process of focusing on and selecting particular
aspects of available task-relevant information while suppressing
other less-relevant aspects (Smith and Kosslyn, 2007), and is dif-
ferent than vigilance- the ability to sustain performance on a
task for a prolonged period of time (Oken et al., 2006). On a
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o approximately 280 mg  (∼0.5–4 mg  kg−1) improved both speed
nd accuracy in rested volunteers (Maridakis et al., 2009a, 2009b;
mith, 2009; Smith et al., 1992). On a focused-attention, choice-
eaction-time test, caffeine (∼100–150 mg  or 1.2–2.0 mg  kg−1)
igniﬁcantly improved response speed in rested subjects, and
ometimes simultaneously improved accuracy as well (Heatherley
t al., 2005; Smith et al., 2005). There is some debate in the liter-
ture regarding the impact of caffeine on simple versus complex
ttention tasks, but Einother and Giesbrecht (2013) concluded that
affeine had positive effects on both. Simple tasks beneﬁtted from
oses ranging from 12.5–400 mg  (∼0.2–5.5 mg kg−1); and more
omplex tasks, to include the rapid visual information processing
ask, the ﬂanker task, and the switch task, beneﬁtted from doses in
he 60–400 mg  (∼0.75–5.5 mg  kg−1) range.
Evaluation of the impact of 3 mg  kg−1 caffeine on categorical
earch, Stroop and ﬂanker tasks led Renda et al. (2015) to conclude
affeine has a general positive impact on attention, and in tasks
nvolving alerting, orienting and (verbal) executive control, caf-
eine positively affects different aspects of attention. These authors
uggested some variability noted in previous studies of caffeine’s
ffects may  be in part due to variations in the genetic makeup
f participants, especially in relation to genes affecting adeno-
ine metabolism. Nevertheless, there appears to be consensus in
he literature that a broad range of caffeine doses exert a positive
mpact on attention, appearing to reach an asymptote at doses of
00–300 mg (∼2.5–4.0 mg  kg−1).
.4. Acute effects on memory
Investigations on the effects of caffeine and short-term mem-
ry have produced mixed results. Warburton et al. (2001) tested
2 rested participants following ingestion of an energy drink
ontaining 80 mg  (∼1 mg  kg−1) of caffeine, and found that while
onsumption of the beverage improved attention and verbal rea-
oning, there were no differences in verbal or non-verbal memory.
hese results tend to support those of Amendola et al. (1998) who
ound that caffeine in doses of 64, 128 and 256 mg  (∼1–3.5 mg  kg−1)
esulted in a dose-dependent improvement in vigilance and mood,
ut had no signiﬁcant effects on subjects’ memory of words pre-
ented in a set word list. Terry and Phifer (1986) conducted a study
n non-sleep-deprived college students and found that 100 mg
∼1.5 mg  kg−1) of caffeine actually led to poorer recall of words, par-
icularly words appearing in the middle or end of the memorized
ist. However, this study was not rigorously controlled.
Studies of the effects of caffeine on other aspects of memory
lso are inconsistent. Caffeine’s effects on retrieval and recognition
emory are variable, and its effects on encoding may  depend on the
ubject’s level of arousal [see Smith (2005) for a detailed review].
hen caffeine has positive effects on speciﬁc aspects of memory,
hey may  be mediated by its effects on lower order functions such as
ttention, and as previously noted, they often follow the U-shaped
ctivation curve. For example, Mahoney et al. (2012) found an effect
f caffeine on false memories in non-habitual users with as little as
 100 mg  dose (∼1.5 mg  kg−1), and while effects peaked at 200 mg
∼2.5 mg  kg−1), a higher 400 mg  (∼5.5 mg  kg−1) dose did not result
n a further increase. Subjects with the highest arousal increases
ue to caffeine administration also tended to produce the highest
alse recall and recognition rates, while veridical verbal memory
as unaffected.
Evaluations of post-training effects of caffeine on cognitive-
nd motor-memory encoding and recall have produced mixed
esults. Hussain and Cole (2015) found that post-training admin-
stration of a 200 mg  (∼2.5 mg  kg−1) dose of caffeine exerted no
igniﬁcant impact on next-day patterns of re-learning, mean per-
ormance learning magnitudes, mean performance learning rates,havioral Reviews 71 (2016) 294–312 299
or mean performance retention on a continuous isometric visuo-
motor tracking task. These results contrast with those of other
investigators who have investigated effects of caffeine on mem-
ory encoding/recall in both animals and humans (Favila and Kuhl,
2014). In particular, they contradict Borota et al. (2014) who found
administration of 200 mg  caffeine during the memory encoding
phase of testing improved subjects’ next-day abilities to correctly
discriminate between previously learned items and similar “lure
items.” Such discrepant ﬁndings may  indicate the effects of caffeine
on encoding and retention depend on the memory task being stud-
ied (Angelucci et al., 1999). Further study of the effects of caffeine
on memory processing is essential to resolve these issues.
3.5. Chronic effects on memory
Most research on memory has focused on the acute effects of
caffeine administration, but there have been a few investigations
on the impact of long-term or habitual caffeine use. These gener-
ally suggest a beneﬁcial effect of caffeine. Epidemiological reports
have suggested a link between chronic caffeine consumption and a
reduced risk of developing neurodegenerative diseases (Cappelletti
et al., 2015), although a recent meta-analysis of observational
studies called the association between coffee/tea consumption
and cognitive disorders (speciﬁcally, dementia, Alzheimer’s dis-
ease, cognitive impairment and cognitive decline) into question
(Kim et al., 2015). Nevertheless, a study of 9003 adults by Jarvis
(1993) found a positive relationship between habitual caffeine
consumption and performance on verbal memory, visuospatial
reasoning and reaction time tasks. These effects became stronger
with increasing age. This is consistent with a study of 1875 adults
conducted by Hameleers et al. (2000), which observed that habit-
ual caffeine consumption was  associated with better long-term,
but not short-term, verbal memory. The results also were par-
tially consistent with those of Johnson-Kozlow et al. (2002) who
observed that elderly women  (but not men) who consumed large
amounts of caffeine throughout their lifetimes performed bet-
ter than non-caffeine drinkers on memory and other cognitive
tasks. Perhaps these memory effects in older adults are associ-
ated with the antiepileptic and neuroprotective improvements that
have theoretically been linked to long-term caffeine consumption
(Fredholm, 1995). Alternatively, they simply may be due to the
fact that healthier (and therefore more cognitively intact) elderly
subjects choose to consume more caffeine than their unhealthy
counterparts as there is good evidence health concerns lead to
curtailment of caffeine consumption (Soroko et al., 1996). Interest-
ingly, Harvanko et al. (2015) failed to observe a positive relationship
between routine self-regulated caffeine consumption and reaction
time, vigilance, response inhibition or decision-making in young
adults, suggesting that while higher average caffeine intake may
attenuate cognitive declines in older adults, a similar effect is not
present in younger subjects.
3.6. Executive function
Relatively few studies have examined the effects of caffeine
intake on higher level “executive” skills that “manage” lower level
functions such as reasoning and decision-making. Thus, there is lit-
tle deﬁnitive information regarding the impact of caffeine on the
ability to resolve cognitive conﬂicts, inhibit automatic or impulsive
responses, plan strategic actions, and ﬂexibly react to changing cir-
cumstances. These important skills of everyday life are difﬁcult to
evaluate. Also, as noted by Brunyé et al. (2010a), there are substan-
tial methodological differences across the few studies examining
caffeine’s effects on executive function. The use of different caffeine
doses, the testing of habitual vs. non-habitual consumers, the wide
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leep restricted, and substantial disparities in the assessment tasks
re just some of the factors contributing to discrepant ﬁndings in
he literature concerning caffeine’s impact on executive functions.
Brunyé et al. (2010b) used the Attention Network Test
ANT) to assess the effects of caffeine on conﬂict-resolution and
mpulsivity-inhibition in rested volunteers, and reported that caf-
eine improved executive control of low habitual caffeine users in
 dose-dependent fashion (reaching an asymptote at 200 mg  or
2.5 mg  kg−1). Brunyé et al. (2010b) also found dose-dependent
mprovements in ANT performance among non-sleep-deprived,
igh habitual caffeine consumers (although a larger 400 mg
∼5.5 mg  kg−1) dose of caffeine was required). Thus, since visual
ocus and impulse control are complex cognitive skills, data from
he ANT support a positive role for caffeine enhancing higher-order
rocesses.
In a study conducted with sleep-deprived volunteers, Gottselig
t al. (2006) failed to detect a beneﬁcial effect of caffeine on higher-
rder cognition assessed by the Random Number Generation (RNG)
est which measures response inhibition and use of non-redundant,
on-stereotypical strategies. The authors found that while 200-
g  (∼2.5 mg  kg−1) doses of caffeine administered at the 11th and
3rd hours of continuous wakefulness didn’t mitigate sleepiness-
elated rule violations and stereotypical responses, it did partially
revent a decline in the number of responses generated. Therefore,
he authors suggested caffeine has positive effects on sustainment
f simple, but not complex cognitive processes degraded by sleep
oss. However, an alternative interpretation, given caffeine’s differ-
ntial effects across the arousal continuum, is the extent of sleep
eprivation generated by Gottselig et al. (2006) was not sufﬁciently
evere to reveal caffeine’s alerting properties.
In contrast to the above, Soar et al. (2016) found that even a
ow dose of caffeine (50 mg  or ∼0.7 mg  kg−1) enhanced executive
unctions as measured by performance on the Jansari assessment
f Executive Functions (JEF©) task. Not only was  overall perfor-
ance on the JEF© enhanced, but individual constructs of planning,
reative thinking, event-based prospective memory, time-based
erspective memory and action-based perspective memory also
ere enhanced compared to a decaffeinated control condition.
nterestingly, similar positive results were not observed on Stroop
nhibitory control despite the fact caffeine generally improved
peed of responding regardless of whether the stimuli were con-
ruent or non-congruent. These ﬁndings call into question the
alidity of Stroop as a measure of executive function. However,
ince inhibitory control is not assessed by the JEF©, it is unclear
hether different conclusions about caffeine and this particular
igher-order process are due to methodological/validity issues or
hether they are due to the fact caffeine actually exerts little con-
rol over response inhibition.
The Tower of London (TOL) and Tower of Hanoi (TOH) tasks
ave been used to assess the effects of caffeine on the execu-
ive skills of strategic planning and impulse control. These tasks
equire participants to rearrange stacks of colored objects on pegs
o match a designated pattern. Optimal performance apparently
elies on subtle differences in executive processing. As has been
he case with other attempts to explore the effects of caffeine on
xecutive function, the results from TOL and TOH studies appear
onfounded by inconsistent design characteristics. Killgore et al.
2009) found a single 600 mg  (∼8.0 mg  kg−1) dose of caffeine given
fter 44 h of sustained wakefulness led to improvements in TOH
ime-to-complete but failed to preserve TOL performance. Despite
peculation as to why the results from these similar tasks were
nconsistent, the authors did not reach any deﬁnitive conclusions. subsequent multi-dose study conducted by Killgore et al. (2014)
ontradicted their earlier study. In that study, repeated 200 mg
∼2.5 mg  kg−1) doses of caffeine given across 3 nights of continuous
akefulness signiﬁcantly improved TOL performance by enhancinghavioral Reviews 71 (2016) 294–312
planning speed, average response time, and throughput efﬁciency
despite having no effect on the overall number of moves required
to solve the puzzles. The authors suggested the observed TOL
improvements may  have been the result of lower-level efﬁciency
enhancements rather than better higher-order solution processing
but, as is the case with other ﬁndings on caffeine and executive
functioning, deﬁnitive conclusions will, as suggested by Stafford
et al. (2007), require additional study.
3.7. Judgment and risk-taking
There is little research on the effects of caffeine on judging future
consequences of current actions, maintaining emotional intelli-
gence and control, rendering accurate self-appraisals, or making
sound judgments. As with the executive skills discussed above, it is
unclear whether caffeine exerts differential effects in rested versus
sleep-deprived individuals, since virtually all studies on risk-taking
and cognitive-affective (emotional) functions have been conducted
on sleep-deprived volunteers. Thus, caffeine’s observed impact in
these studies may  be secondary to caffeine’s alerting properties.
One study of caffeine’s effects on non-sleep-deprived habitual users
found no improvements in attention, concentration, processing and
reaction speed; yet there were positive effects on self-reported
energy and activity, and self-appraisals of performance capacity
(Ullrich et al., 2015). Thus, the authors concluded caffeine made
subjects “feel smarter” even in the absence of objective evidence
that this was the case.
Overall, studies show that caffeine exerts little impact on
complex judgment and risky-decision-making (Killgore, 2011).
However, in one investigation 600 mg  (∼8 mg kg−1) of caffeine
improved ability of sleep-deprived subjects to make subtle judg-
ments about complex emotional expressions (Huck et al., 2008). In
contrast, Killgore et al. (2007) examined the impact of repeated
200 mg  (∼2.5 mg  kg−1) doses of caffeine (given every 2 h for
a total of 800 mg  or ∼10.5 mg  kg−1) on the performance of a
gambling task after 51 and 75 h of continuous wakefulness and
found caffeine was  ineffective at ameliorating sleepiness-related
increases in risk-taking. In addition, an earlier study of effects of
sleep loss and caffeine on ability to accurately judge the humor
content of verbal statements and visual images (Killgore et al.,
2006) found administration of a 600 mg  dose did not restore
humor appreciation (a highly-developed cognitive-affective abil-
ity) to pre-sleep-deprivation levels, even though caffeine-related
improvements in vigilance were observed. The absence of caffeine’s
effect on humor is consistent with subsequent observations regard-
ing the impact of caffeine (and other stimulants) on risk-taking.
Killgore et al. (2008) found that a 600 mg  dose of caffeine failed
to normalize the propensity of sleepy subjects to engage in dan-
gerous behaviors, to seek out loud and exciting activities, or to
appropriately balance risk-taking cost/beneﬁt perception (i.e., the
cost of pushing limits versus the beneﬁts of playing it safe). In sum-
mary, the limited evidence available suggests that while caffeine
effectively promotes alertness and vigilance in sleep-deprived indi-
viduals, its impact on complex judgment, emotional discernment,
and decision-making is uncertain.
3.8. Summary − cognitive performance
Caffeine increases alertness when individuals are rested or
fatigued (Smith, 2011), and the effects are dose-related (Davidson
and Smith, 1991; Nehlig, 2010). Moderate doses (100–300 mg
or ∼1.5–3.0 mg  kg−1) typically are beneﬁcial while higher doses
(above 400 mg  or ∼5.5 mg  kg−1) are more likely to result in anx-
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Caffeine exerts its most reliable beneﬁcial effects on vigilance
asks. Caffeine’s positive effects are present in rested individu-
ls (Lieberman et al., 2010, 1987b, 1987a; Smith, 2005) and in
leep-deprived individuals (Lieberman et al., 2002; Smith, 2011;
eiss and Laties, 1962; Wesensten et al., 2002, 2004), and likely
ccur because caffeine reverses decrements in alertness associated
ith prolonged maintenance of attention. Caffeine also reliably
nhances the fundamental cognitive processes that underlie all
ypes of performance such as reaction time (Nehlig, 2010; Smith,
002) and attention (Einother and Giesbrecht, 2013; Smith, 2011).
he acute effects of caffeine on memory are less consistent and
ppear, among other things, to be inﬂuenced by whether or not the
ask is boring or engaging (Amendola et al., 1998; Anderson and
evelle, 1983). The chronic effects of caffeine intake on memory
ay  be positive (Hameleers et al., 2000) perhaps due to neuro-
rotective effects (Fredholm, 1995). However, the evidence is not
eﬁnitive and has been challenged by other studies (Boxtel et al.,
003). The effects of caffeine on higher-order executive functions
re unclear as such functions are especially difﬁcult to assess;
herefore, additional research in rested, as well as sleep-deprived,
ndividuals is warranted (Killgore, 2011; Lieberman, 1992).
In summary, across a wide array of circumstances, moderate
oses of caffeine (approximately 32–300 mg  or ∼0.5–4.0 mg  kg−1)
mprove vigilance, learning, and mood. Caffeine may  be particularly
eneﬁcial when factors that degrade performance are present.
. Effects on physical performance
Caffeine’s ergogenic properties were ﬁrst reported over 100
ears ago (Rivers and Webber, 1907). Differences in daily use of
he drug and exercise routines were identiﬁed as important factors
or interpreting responses to caffeine ingestion in this early report,
hich only had two participants. Other early reports also had low
tatistical power due to the small numbers of participants (Alles
nd Feigen, 1942; Asmussen and Bøje, 1948; Foltz et al., 1942a,
942b; Ganslen et al., 1964; Haldi et al., 1941; Margaria et al., 1964;
hornton et al., 1939). In addition, it was noted there were ‘respon-
ers’ and ‘non-responders’ to caffeine (Alles and Feigen, 1942;
oltz et al., 1942a; Thornton et al., 1939). Reports also cited differ-
nces in response between exercise trained and untrained subjects
Foltz et al., 1942a, 1942b, 1942c), the duration of exhausting work
Asmussen and Bøje, 1948) or dose ingested (Alles and Feigen,
942; Haldi et al., 1941) and the relationship between reduced sen-
ations of pain and fatigue and improvements in work performance
ollowing the ingestion of the drug (Foltz et al., 1942a). Rarely
ere the doses normalized to the body mass of the participants
Haldi et al., 1941) but typically absolute amounts of 200–300 mg
or 3–4 mg  kg−1) were infused (Foltz et al., 1942a) or ingested (Alles
nd Feigen, 1942; Asmussen and Bøje, 1948; Haldi and Wynn, 1946;
argaria et al., 1964; Thornton et al., 1939).
Prior to 2004, athletes were disqualiﬁed from Olympic compe-
ition if urine levels of caffeine exceeded 12 g mL−1. Graham and
priet (1991) examined running and cycling performance as well
s urine concentrations of caffeine following a 9 mg  kg −1 dose. Per-
ormance improved for both modes of exercise. Although mean
rinary caffeine concentrations were below 12 g·mL−1, two par-
icipants exceeded this concentration following one or both of the
erformance tests, implying that a somewhat lower dose of caffeine
ould be required to ensure that these threshold limits of detection
ere not exceeded. Since caffeine was removed from the banned
ubstance list of the World Anti-Doping Agency in 2004, there has
een renewed research interest about the drug’s impact in numer-
us sporting activities. In addition, use of caffeine by well-trained
thletes during competition is common but athletes receive little
nformation about the moral or ethical issues concerning the use ofhavioral Reviews 71 (2016) 294–312 301
caffeine as an ergogenic aid (Chester and Wojek, 2008). The follow-
ing section reviews evidence for the ergogenic effects of caffeine on
physical performance and is subdivided into activities involving:
1) prolonged endurance exercise; 2) muscle strength and muscle
endurance; and 3) high-intensity exercise and intermittent sprints.
Section 4.4 also includes a discussion of the effects of caffeine on
muscle pain and ratings of perceived exertion as they relate to
changes in exercise performance following caffeine ingestion.
4.1. Endurance exercise
The evidence that either supports or refutes caffeine’s effect on
endurance exercise performance is summarized in Supplementary
Table 2. Of the 59 studies described, 46 or 78% presented ergogenic
ﬁndings for some or all of their experimental trials involving caf-
feine supplementation.
It was initially proposed by Costill and colleagues (Costill
et al., 1978; Essig et al., 1980) that following a 4–5 mg  kg−1
(∼300–400 mg  for a 75 kg individual) dose of caffeine, its stimu-
latory actions on free fatty acid release from adipose tissue could
spare muscle glycogen utilization during exercise and prolong per-
formance during exhaustive submaximal exercise. The drug’s effect
on intramuscular glycogen utilization during exercise, however,
was not replicated in subsequent work following caffeine inges-
tion of 6 mg·kg−1 (∼450 mg)  (Graham et al., 2000; Greer et al.,
2000; Jackman et al., 1996; Laurent et al., 2000). Graham et al.
(2000) also conclusively demonstrated using direct Fick measures,
from leg blood ﬂow and arterial and venous blood sampling, and
muscle biopsies that neither carbohydrate nor fat metabolism were
altered during 60 min  of exercise at 70% V˙O2max following the inges-
tion of caffeine. The mechanism currently believed to account for
the ergogenic effects of caffeine is CNS activation resulting from
adenosine receptor A1 and A2a blockade (Davis et al., 2002; Zheng
et al., 2014), not a shift in fuel utilization (Costill et al., 1978; Essig
et al., 1980). As noted earlier in Section 2, adenosine A1 and A2a
receptors form functional heteromers with dopamine D1 and D2
receptors. Blocking of adenosine A2a receptors with caffeine, for
example, promotes a direct excitatory potentiation of D2 receptors
and increases psychomotor activity in animals (Ferré, 2016).
The ergogenic response to caffeine during endurance exercise
is affected by several factors, such as dose (Desbrow et al., 2009;
Graham and Spriet, 1995), training status (O’Rourke et al., 2008),
timing of ingestion (Conway et al., 2003; Cox et al., 2002), history
of caffeine use (Bell and McLellan, 2002), withdrawal effects (Irwin
et al., 2011; Van Soeren and Graham, 1998), source of caffeine
(Graham et al., 1998; Hodgson et al., 2013) and the performance
measures used (Bridge and Jones, 2006; Doherty and Smith, 2004;
Ganio et al., 2009). In addition, studies have presented individual
as well as mean changes to demonstrate there are ‘responders’ and
‘non-responders’ to the effects of caffeine (Desbrow et al., 2009;
Jackman et al., 1996; Spriet et al., 1992). It remains unclear whether
these differences in response are related to genetic polymorphisms
discussed earlier (Graham et al., 2008) and/or are due to day-to-day
individual variation in performance.
In most research studies, caffeine has been ingested as a cap-
sule or dissolved in a drink approximately 1 h prior to the start
of exercise, providing sufﬁcient time for absorption and attain-
ment of peak circulating concentrations (Blanchard and Sawers,
1983; Robertson et al., 1981), although peak performance has
not necessarily coincided with attainment of peak caffeine con-
centrations (Skinner et al., 2013) and time to peak concentration
varies considerably among individuals − anywhere from 0.5 to 3.0 h
(Desbrow et al., 2009; Skinner et al., 2013). As depicted in Fig. 3, the
ergogenic response to the drug is evident over a range of plasma
concentrations. Dose response studies have typically reported opti-
mal  performance beneﬁts with moderate doses between 3 and
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Fig. 3. The relationship between caffeine dose and circulating plasma concentra-
tions for their effect on time-to-exhaustion or time-trial studies on endurance
exercise performance. In these studies caffeine was provided approximately 1 h or
longer before exercise. Open symbols indicate a non-signiﬁcant ﬁnding whereas
closed symbols reported signiﬁcant effects. Circles, squares and triangles indicated
that study participants were regular caffeine users, non-users or a mixture of both,
respectively. Data are presented from 27 papers that reported circulating concentra-





























exercise tolerance in the heat (Armstrong et al., 2007; Zhang et al.,pproximating 15–20 M appears necessary before a predominance of positive ﬁnd-
ngs  become evident.
 mg kg−1 (∼250–500 mg)  rather than with higher doses (Bruce
t al., 2000; Cadarette et al., 1982; Graham and Spriet, 1995), as
igh doses can induce negative side-effects such as gastrointestinal
istress, or an asymptotic ergogenic response in spite of increased
ose and circulating concentration (Desbrow et al., 2012; McLellan
nd Bell, 2004). In addition, with one exception (Jenkins et al.,
008), performance is not improved when caffeine doses are below
 mg kg−1 ingested approximately 1 h prior to exercise (Cadarette
t al., 1982; Desbrow et al., 2009; Ryan et al., 2013). It should also
e noted the ergogenic response to caffeine is maintained for sev-
ral hours following ingestion of a moderate 5 mg  kg−1 (∼375 mg)
ose of the drug despite falling circulating concentrations (Bell and
cLellan, 2002, 2003).
Collectively, these data imply that the ergogenic response to
affeine is dependent upon attaining a threshold circulating con-
entration of approximately 15–20 M (see Fig. 3), a concentration
ufﬁcient to block adenosine receptors. This observation is con-
istent with the lack of an ergogenic response observed by Van
oeren and Graham (1998) when plasma caffeine concentration
as 10 M prior to the placebo trial for the no withdrawal phase
f their experimental design. This observation is also consistent
ith the ergogenic response observed by Graham and Spriet (1995)
hen plasma concentrations reached 18 M prior to exercise
ollowing the ingestion of 3 mg  kg−1 of caffeine. This threshold con-
entration appears to be lower for non-users of the drug (Bell and
cLellan, 2002). Furthermore, exercise itself may  alter the sensitiv-
ty of adenosine receptors and lower the threshold concentrationhavioral Reviews 71 (2016) 294–312
such that a smaller dose provided during or at the beginning of
exercise may  be equally or more effective than similar or larger
doses provided 1 h prior to exercise (Cox et al., 2002; Ryan et al.,
2013). Likewise, smaller doses provided during warm-up exercise
immediately prior to performance testing (Lane et al., 2014) or
immediately prior to and during exercise (Hogervorst et al., 2008;
Kovacs et al., 1998) can be ergogenic and may  be as effective as a sin-
gle larger dose ingested 1 h prior to exercise (Conway et al., 2003).
Although the effects of acute exercise on adenosine receptor and
caffeine sensitivity are not known, a single 1-h bout of exercise has
been reported to alter the adenosine receptor-mediated response
to insulin in the soleus muscle of the rat (Langfort et al., 1993).
Thus, it is conceivable that sensitivity of the adenosine receptors to
caffeine is altered during, and for several hours following, a single
exercise bout.
Since absorption of caffeine is slowed following ingestion of food
and the circulating concentration of the drug is reduced (Dews,
1982; Fleischer et al., 1999), a given dose ingested in a fasted or non-
fasted state may  lead to circulating concentrations that are below or
above, respectively, the threshold concentration necessary to gen-
erate an ergogenic response. For example, doses of caffeine at or
below 4 mg  kg−1 (∼300 mg)  ingested following a meal and prior
to exercise can lead to circulating concentrations that are non-
ergogenic (Desbrow et al., 2009; Skinner et al., 2010), whereas this
same dose provided in a fasted state prior to exercise can lead to
improved performance (Lane et al., 2013; McLellan and Bell, 2004).
In addition, although plasma caffeine concentrations may  be lower
when ingested following a meal, these concentrations may still lead
to an ergogenic effect if exercise has been performed earlier in the
day (Bell and McLellan, 2003), providing additional evidence that
acute exercise itself increases adenosine receptor sensitivity to a
given circulating concentration of the drug.
4.1.1. Exercise performance in the heat
Caffeine’s ability to induce mild diuresis (Wemple et al., 1997)
and thermogenic (Ely et al., 2011; Poehlman et al., 1985) effects
at rest have been postulated to adversely impact exercise perfor-
mance in the heat (Falk et al., 1990; Wemple et al., 1997). Some
investigations have reported an increase in core temperature fol-
lowing caffeine ingestion during exercise in the heat (Cheuvront
et al., 2009; Ely et al., 2011; Kim et al., 2011; Millard-Stafford et al.,
2007), but often these increases are observed at rest and the change
in heat storage during exercise is similar to placebo conditions
(Cheuvront et al., 2009; Ely et al., 2011; Kim et al., 2011). In con-
trast, several studies have shown that caffeine, in doses ranging
from 3 to 9 mg  kg−1 (∼250–700 mg), has no effect on the core tem-
perature response during prolonged exercise in normal (∼20 ◦C)
(Dunagan et al., 1998; Ganio et al., 2011a), warm (∼25–30 ◦C) (Falk
et al., 1990; Wells et al., 1985) or hot environments (>30 ◦C) (Del
Coso et al., 2009; Ganio et al., 2011a; Roti et al., 2006; Wemple et al.,
1997). In addition, caffeine does not inﬂuence forearm blood ﬂow
(Del Coso et al., 2009), sweat rate or ﬂuid-electrolyte balance (Del
Coso et al., 2009; Ganio et al., 2011a; Millard-Stafford et al., 2007;
Roti et al., 2006; Wemple et al., 1997), urine production (Ganio et al.,
2011a; Millard-Stafford et al., 2007; Wemple et al., 1997) or heat
storage (Ely et al., 2011) during exercise in the heat. Further, there
is no evidence to support the contention that chronic consump-
tion of caffeine alters ﬂuid-electrolyte balance or hydration status
(Armstrong, 2002; Maughan and Grifﬁn, 2003; Roti et al., 2006).
Thus the ingestion of caffeine in doses up to 9 mg  kg−1 (∼700 mg)
prior to or during exercise in hot environments should not be
avoided due to fear of increased ﬂuid-electrolyte loss or a reduced2015).
Caffeine ingestion has been shown to increase peak cycling
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eduction in maximal voluntary contraction force and motor unit
ctivation observed following exercise without drug ingestion (Del
oso et al., 2008). Since electrically evoked contractile properties
ere not affected by caffeine, the authors concluded caffeine had
nﬂuenced CNS motor unit activation rather than directly affect-
ng muscle function. To date, only one study has examined the
rgogenic effects of caffeine in both cool and hot environments with
he same well-hydrated participants (Ganio et al., 2011a). Under
hese conditions, although performance was decreased in the heat,
he ergogenic effect of the 3 mg·kg−1 (∼250 mg)  dose of caffeine
as similar in both the cool and hot environments (Ganio et al.,
011a). The available evidence clearly indicates caffeine does not
xert a negative inﬂuence on exercise performance in the heat.
.2. Muscle strength and endurance
The evidence-base that either supports or refutes caffeine’s
ffect on muscle strength and associated tests of muscular
ndurance is summarized in Supplementary Table 3. Two-thirds of
he 33 papers presented in this Supplementary Table described an
rgogenic effect for experimental trials involving caffeine ingestion.
Very high, toxic doses of caffeine enhance intracellular Ca2+
elease (see Fig. 1) and directly impact the excitation-contraction
oupling process and generation of force. However, as reviewed
lsewhere (Tallis et al., 2015), at a physiological concentration of
0 M,  caffeine increased contractility, cytosolic Ca2+ release and
rolonged fatigue in an isolated mammalian skeletal muscle ﬁber
reparation. Further, in intact human skeletal muscle, ingestion
f low to moderate doses of caffeine has been shown to increase
orce generation during low-frequency stimulation (Lopes et al.,
983; Mora-Rodriguez et al., 2012; Tarnopolsky and Cupido, 2000),
onsistent with a direct effect of the drug on Ca2+ release. In con-
rast, Cafarelli and colleagues have shown that caffeine increased
otor unit activation and maximal voluntary contraction force
ithout affecting measures of motorneuron excitability or contrac-
ile properties, implying that the drug’s effect on maximal force
as occurring at a supraspinal level (Kalmar and Cafarelli, 1999;
laskett and Cafarelli, 2001). It is not clear why some ﬁndings imply
 direct effect of caffeine on intramuscular Ca2+ release whereas
ther ﬁndings do not.
Others have reported that maximal isometric force and isoki-
etic torque throughout a range of contraction velocities were
ncreased following caffeine ingestion (Bazzucchi et al., 2011; Del
oso et al., 2012; Duncan et al., 2014; Park et al., 2008), an effect
ttributed to faster muscle ﬁber conduction velocity (Bazzucchi
t al., 2011), as well as increased motor unit activation (Duncan
t al., 2014; Park et al., 2008). Based on a meta-analysis, Warren
t al. (2010) concluded caffeine increased strength of the leg
xtensors by enhancing motor unit activation and increasing mus-
ular endurance during open-ended tests. These conclusions are
onsistent with the proposed central command and arousal and
otivation mechanisms hypothesized to explain caffeine’s effects
n physical performance.
.3. High-intensity exercise
Supplementary Table 4 summarizes the effects of caffeine on
he performance of high-intensity exercise. Fifty-one or 69% of
he studies described in Supplementary Table 3 were associated
ith an ergogenic effect following doses between 3–10 mg  kg−1
∼250–750 mg)  of caffeine within their experimental design.
The energy demand during high-intensity exercise is initiallyenerated through anaerobic pathways but as the duration of
ffort increases a greater proportion of energy turnover is supplied
hrough aerobic metabolism. The effects of caffeine in doses rang-
ng from 3 to 10 mg  kg−1 (∼250–750 mg)  have been studied duringhavioral Reviews 71 (2016) 294–312 303
incremental exercise to maximum, tests that require maximal all-
out efforts lasting 5–75 s, high-intensity repeated sprints, tests of
agility and high-intensity tests to exhaustion or time-trials lasting
several minutes. Typically, caffeine has no effect on total exercise
time during an incremental test to maximum (Dodd et al., 1991;
Powers et al., 1983). In addition, peak power and fatigue during
all-out efforts lasting less than 60 s are most often unaffected by
the drug (Bell et al., 2001; Glaister et al., 2012; Greer et al., 1998).
However, as the duration of the all-out effort extends beyond 60 s,
enhanced performance is observed (Bell et al., 2001; Jackman et al.,
1996; Silva-Cavalcante et al., 2013; Simmonds et al., 2010; Wiles
et al., 1992) and has been attributed to a direct effect on the active
muscle through an increased glycolytic ﬂux and accumulated oxy-
gen deﬁcit (Bell et al., 2001) or anaerobic power (Silva-Cavalcante
et al., 2013), maintenance of intramuscular electrolyte homeosta-
sis (Jackman et al., 1996; Simmonds et al., 2010), or CNS effects, as
indicated by a reduced perception of effort (Wiles et al., 1992).
Repeated all-out brief sprints and intermittent high-intensity
efforts are often required in team and court sports. Studies have
reported mixed results for the impact of caffeine doses between
3–6 mg  kg−1 (∼250–450 mg)  on speed, power and fatigue during
these sports. For example, caffeine had no effect on 10 repeated
20-m sprints completed with about 6-s rest between each sprint
(Paton et al., 2001) or repeated sets of all-out 4-s cycling sprints
with 20-s rest between sprints (Lee et al., 2014a, 2014b). Others
have also reported that following caffeine ingestion reduced peak
and average power or the time to reach peak power during repeated
all-out efforts lasting 30- or 60-s (Crowe et al., 2006; Greer et al.,
1998). In contrast, caffeine has improved the motor skills neces-
sary to be successful during simulated taekwondo, tennis, rugby
and soccer matches (Hornery et al., 2007; Lara et al., 2014; Roberts
et al., 2010; Santos et al., 2014), and improved agility, decision and
movement time before and after four, 20-min circuits that repli-
cated the movement patterns and exercise demands in team sports
(Duvnjak-Zaknich et al., 2011). Some of the discrepancy across
these ﬁndings can be attributed to the duration of the rest interval
between the repeated high-intensity exercise bouts with no effects
being observed following drug ingestion when recovery intervals
are less than 10 s (Paton et al., 2001). Lee et al. (2012) reported that
caffeine’s ergogenic effects on peak and mean power during 4-s
sprints remained evident during repeated sets with 90-s recovery
intervals, but with shorter recovery intervals of 20 s performance
on caffeine versus placebo actually decreased during the second set
of 12 repeated sprints.
Although direct effects of caffeine on the muscle membrane
potential have been suggested to explain the ergogenic effects
of the drug during these high-intensity efforts (Simmonds et al.,
2010), reports of CNS effects of caffeine that reduce sensations of
pain and effort should not be discounted (Plaskett and Cafarelli,
2001; Roberts et al., 2010; Wiles et al., 1992).
4.4. Effects on muscle pain and perceived exertion
Adenosine levels increase during skeletal muscle contraction
(Fredholm, 1995; Marshall, 2007). Because pain is induced by
adenosine binding to A1 receptors (Gaspardone et al., 1995;
Sawynok, 1998), studies have examined whether caffeine can
reduce the sensations of pain experienced during various types of
exercise. These studies report reduced sensations of pain following
caffeine ingestion during ischemic arm exercise (Myers et al., 1997),
moderate- (Duncan and Hankey, 2013; Ganio et al., 2011b; Motl
et al., 2006; O’Connor et al., 2004) and high-intensity (Gliottoni
et al., 2009; Gliottoni and Motl, 2008) cycling, cross-country ski-
ing (Stadheim et al., 2013, 2015) and following resistance exercise
(Maridakis et al., 2007). The magnitude of the drug effect appears
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’Connor et al., 2004), level of pain (Gonglach et al., 2016), ambient
emperature (Ganio et al., 2011b), sex (Motl et al., 2006; O’Connor
t al., 2004) and anxiety sensitivity (Gliottoni and Motl, 2008), but
ppear unrelated to habitual use (Gliottoni et al., 2009). Following
everal sets of eccentric contractions that produce muscle soreness,
affeine has also been shown to reduce sensation of pain during
aximal voluntary isometric or submaximal eccentric contractions
4- or 48-h post exercise (Maridakis et al., 2007).
In a similar context, ratings of perceived exertion during or fol-
owing exercise are often reduced and time-to-exhaustion or total
ork increased following caffeine ingestion (Bell and McLellan,
002, 2003; McLellan and Bell, 2004) or perceived exertion remains
he same while time-trial performance improves (Bruce et al., 2000;
esbrow et al., 2012; Wiles et al., 1992), indicating more work
an be accomplished or higher power outputs generated follow-
ng the ingestion of the drug. Using meta-analysis, Doherty and
mith (2005) reported ratings of perceived exertion were reduced
y approximately 6% with caffeine ingestion during constant load
xercise and that change in these ratings could account for almost
0% of the variance in time-to-exhaustion tests following inges-
ion of caffeine. Together with lower ratings of perceived exertion,
ffective states of pleasure and arousal are increased during con-
tant workrate exercise (Duncan and Hankey, 2013), which could
urther contribute to the ergogenic effects of the drug. The effects
f caffeine on cognitive components of exercise such as perceived
xertion and pain provide additional support for a predominantly
entral mechanism of action of the compound.
.5. Summary − effects on physical performance
The antagonism of adenosine receptors in the CNS and the resul-
ant interaction with dopamine receptors is now regarded as the
rinciple mechanism of caffeine’s action (Davis et al., 2002; Ferré,
016). It is also now apparent that caffeine has ergogenic prop-
rties that can impact performance during many different types
f exercise. Of the papers reviewed in Supplementary Tables 2–4,
lmost 80% reported positive ﬁndings during endurance exercise,
hereas two-thirds reported ergogenic effects for measures of
uscle strength and associated tests of muscular endurance or
igh-intensity exercise. Except for very short duration anaerobic
xercise, there was also a common thread throughout these studies,
egardless of the type of exercise, that caffeine reduced percep-
ion of effort (Doherty and Smith, 2005) and lowered sensations of
ain (Gliottoni et al., 2009; Motl et al., 2003, 2006; O’Connor et al.,
004; Plaskett and Cafarelli, 2001; Stadheim et al., 2013, 2015).
otwithstanding the large body of evidence of caffeine’s central
ffects via adenosine receptors, there have been studies revealing
 direct action of caffeine following very high doses of 6–10 mg  kg−1
∼450–750 mg)  on skeletal muscle either through an effect on Ca2+
elease from the sarcoplasmic reticulum (Lopes et al., 1983; Mohr
t al., 1998; Tarnopolsky and Cupido, 2000) or through reduced K+
fﬂux (Lindinger et al., 1993; Mohr et al., 2011). In addition, it is
pparent that the ergogenic effects of the drug vary, and substan-
ial individual differences in response to caffeine exist. Moreover,
ery high doses (6 or more mg  kg−1 or greater than ∼450 mg)  can
egrade physical and cognitive performance as they can produce
nxiety and severe gastro-intestinal distress (see Section 6). These
ndividual differences in response to the drug indicate that athletes
hould always test effects of caffeine on themselves prior to compe-
ition to optimize dose, timing of ingestion and period of abstinence
rior to competition.havioral Reviews 71 (2016) 294–312
5. Combined effects on physical and cognitive performance
5.1. Exercise studies
Since caffeine has positive effects on cognitive and physical per-
formance when they are studied separately, some experimental
designs have tested the drug’s effects on both measures of perfor-
mance. Hogervorst and colleagues (Hogervorst et al., 1999; Kovacs
et al., 1998) examined the impact of various doses of caffeinated
carbohydrate electrolyte drinks on measures of cognitive function
before and after a 1-h cycling time-trial. Moderate (3.2 mg kg−1
or ∼250 mg)  and high (4.5 mg kg−1 or ∼350 mg)  doses of caffeine
improved time-trial performance (Kovacs et al., 1998), whereas
the low (2.1 mg  kg−1 or ∼150 mg)  and moderate doses improved
many aspects of cognitive function, such as attention, recogni-
tion memory and complex psychomotor speed, following exercise
(Hogervorst et al., 1999). Only selective attention was  improved
with the high dose of caffeine following exercise. Thus, lower doses
favored cognitive function and higher doses improved exercise
performance so a moderate dose should be recommended if both
physical performance and cognitive function improvements are
important. Subsequently, Hogervorst et al. (2008) reported that
three 100 mg  (∼1.5 mg  kg−1) doses of caffeine consumed before
and during exercise improved both time-to-exhaustion and con-
centration, response speed and detection, and complex processing
during, as well as following, exercise.
The exercise challenge selected by Hogervorst and colleagues
(Hogervorst et al., 1999; Kovacs et al., 1998), as well as the tests
chosen to assess cognitive function, are also important to con-
sider. Other studies have not reported consistent positive effects
on both physical and cognitive function following caffeine inges-
tion (Bottoms et al., 2013; Carr et al., 2008; Crowe et al., 2006).
For example, using a 6 mg  kg−1 (∼450 mg)  dose of caffeine, Crowe
et al. (2006) reported no effects on repeated all-out exercise last-
ing 60 s, as well as no effects on reaction time or recall assessed
before or after the all-out efforts. Similarly, no effects on simple
or complex reaction times measured before or after exercise were
noted following 3 or 6 mg kg−1 (∼250 or 450 mg) of caffeine, yet
faster average sprint times were recorded during 5 repeated sets
(Carr et al., 2008) or fewer misses were observed during a simulated
fencing competition (Bottoms et al., 2013). Thus both the dose and
timing of caffeine ingested, the exercise challenge selected and the
tests chosen to assess cognitive function are important factors that
could explain these discrepant ﬁndings.
In the next section strong evidence of caffeine’s beneﬁcial effect
on both cognitive and physical performance is presented in the
context of various real-world occupational activities.
5.2. Occupational studies
Military operations could beneﬁt from the use of caffeine since
soldiers are required to engage in physically and cognitively chal-
lenging activities in extreme environments, while carrying heavy
loads (Nindl et al., 2013), with little opportunity to sleep, leading
to extensive decrements in cognitive function (Lieberman et al.,
2005). Lieberman et al. (2002) were the ﬁrst to study the effective-
ness of caffeine ingestion on cognitive function during a stressful
military training exercise which involved 80-h of sleep restriction
in combination with extensive physical and mental challenges.
Following 72-h of sleep deprivation, a 200 or 300 mg  (∼2.5 or
4 mg  kg−1) dose of caffeine improved several measures of cognitive
function including vigilance, reaction time, attention and mood, as
well as improving marksmanship (Lieberman et al., 2002; Tharion
et al., 2003). Unfortunately, tests of physical performance were not
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McLellan and co-workers expanded on the theme of caffeine
s a physical and cognitive aid in the military environment with
 series of laboratory (McLellan et al., 2004; Tikuisis et al., 2004)
nd ﬁeld studies (McLellan et al., 2005a,b, 2007) designed to simu-
ate the rigors of sustained operations for soldiers. The caffeine was
rovided in a gum due to its more rapid absorption through the
uccal mucosa (Kamimori et al., 2002). During an initial laboratory
tudy, both marksmanship and physical performance, as indicated
y treadmill run times-to-exhaustion and a sandbag piling task,
mproved when a total caffeine dose of 600 mg  (∼8 mg  kg−1) was
rovided during overnight hours (McLellan et al., 2004; Tikuisis
t al., 2004). A subsequent ﬁeld study with personnel from a
onventional unit assessed live-ﬁre marksmanship accuracy and
igilance, running performance and overnight vigilance in an urban
peration setting during a 50-h training exercise (McLellan et al.,
005a). Following the ﬁrst overnight period that restricted sleep
o 3 h, soldiers received either placebo or a total caffeine dose of
00 mg  during the second overnight period. Marksmanship perfor-
ance, assessed by ability to detect targets and shooting accuracy,
nd vigilance was maintained at control, non-sleep-deprived lev-
ls for those receiving caffeine, whereas both measures decreased
igniﬁcantly for the placebo group. However, 5-km run times
erformed approximately 5 h after the last caffeine dose slowed
qually for both groups following the training exercise. This lack of
rgogenic response is consistent with the lack of effects of caffeine
bserved when testing is more than 3 h after dosing and partici-
ants are regular users of caffeine (Bell and McLellan, 2002).
Two additional ﬁeld studies were designed to assess the effec-
iveness of caffeine in highly-trained Special Forces personnel
McLellan et al., 2005b, 2007). During the ﬁrst of these studies, vig-
lance, assessed with an observational ﬁeld task, was maintained at
ontrol levels with administration of 200-mg (∼2.5 mg  kg−1) doses
f the drug but declined by 30% during the overnight testing period
ith placebo (McLellan et al., 2005b). Marksmanship accuracy, tar-
et engagement and response time were unaffected by caffeine in
his study. In addition, 6.3 km run times signiﬁcantly improved for
hose receiving 200 mg  of caffeine approximately 1 h before the run,
hereas run times slowed for those receiving placebo.
A subsequent ﬁeld study was designed to assess caffeine’s
mpact on physical and cognitive performance during repeated
ights of sustained wakefulness followed by periods of restricted
aytime sleep (Kamimori et al., 2015; McLellan et al., 2007).
igilance was again maintained at control levels with the use
f repeated 200-mg doses of caffeine, whereas performance
ecreased during the overnight periods with placebo. The use of
affeine also maintained and improved physical performance dur-
ng an obstacle course test.
Clearly, these studies collectively demonstrate the beneﬁts of
sing caffeine by both conventional and Special Forces personnel to
aintain cognitive and physical performance during periods of sus-
ained operations when opportunities for normal sleep are reduced
r removed altogether. The U.S. Department of Defense has made
affeine gum available for uniformed personnel and included it in
ertain specialty rations (McClung et al., 2011). Repeated doses of
pproximately 200 mg  every 2 h appear to be an effective strategy
o maintain cognitive performance during an overnight period of
ustained wakefulness, as well as to offset decrements in physical
erformance associated with sleep deprivation (Kamimori et al.,
015; McLellan et al., 2004, 2005a, 2005b, 2007).
In a similar context, the use of caffeine could prove useful
or athletes who compete after travel across multiple time zones
hen their sleep is disrupted or in occupations demanding physical
ork and high levels of concentration and alertness with restricted
pportunity for sleep, such as factory shift workers, truck drivers
nd pilots (Doan et al., 2006; Ker et al., 2010; Reyner and Horne,
000; Ronen et al., 2014; Sharwood et al., 2013; Souissi et al., 2014).havioral Reviews 71 (2016) 294–312 305
For example as highlighted in Section 3.2, the use of specially-
formulated caffeinated foods provided to pilots during a simulated
10-h high-altitude nighttime mission maintained cognitive per-
formance at baseline levels, whereas performance signiﬁcantly
decreased during placebo conditions (Doan et al., 2006). Consistent
effects of caffeine, however, were not observed during performance
of the ﬂight simulator task. Realistic studies similar to these con-
ducted by military researchers should be conducted to evaluate the
beneﬁts and risks of caffeine use in a variety of at-risk occupations.
The ability of caffeine to alleviate driver sleepiness has also been
studied during both simulated and real driving tasks. Reyner and
Horne (2000) reported that a 200 mg  (∼2.5 mg kg−1) dose of caf-
feine provided following a night of restricted sleep (limited to 5 h)
reduced the number of unintentional lane crossings compared with
placebo throughout a subsequent 2-h simulated driving task. Fol-
lowing a night of total sleep deprivation, however, this same dose
of caffeine was  effective for only 30 min  of the driving task, indi-
cating that a larger and/or more frequent dosing of caffeine might
be required to restore performance under these conditions. Fewer
lane position and steering wheel deviations were also observed
during a simulated driving task on a rural road for 150 min  follow-
ing the ingestion of 160 mg  (∼2 mg  kg−1) of caffeine, but driving
performance was  improved for longer if a short rest was included
after 100 min  of driving (Ronen et al., 2014). Nighttime perfor-
mance assessed by unintentional line crossings during 200 km of
real highway driving was also improved following the ingestion of
coffee (with 200 mg  caffeine) compared with decaffeinated coffee,
although for 3 of 12 participants performance was  not restored to
baseline daytime conditions (Philip et al., 2006). Interestingly, the
inclusion of a short nap prior to nighttime driving was an equally
effective countermeasure as caffeine for younger (Philip et al., 2006)
but not middle-aged participants (Sagaspe et al., 2007). It is also
noteworthy that the reported use of caffeinated products by long-
haul professional drivers for the purpose of staying awake was
signiﬁcantly associated with a 63% reduced likelihood of a road
accident (Sharwood et al., 2013).
Without the added stress of sleep deprivation, repeated dos-
ing that totals approximately 300 mg  (∼4 mg  kg−1) of caffeine
appears sufﬁcient to improve both physical and cognitive function
(Hogervorst et al., 2008, 1999; Kovacs et al., 1998). That caffeine
improves both physical and cognitive performance during periods
of sleep deprivation suggests these effects are mediated by similar
processes. Since sleep loss is known to degrade sensory informa-
tion processing, attention, and motor activity, in part because of
cortex-basal ganglia-thalamus-cortex circuit impairment associ-
ated with decreased dopaminergic activity in the striatum and
increased adenosine in the cortex and striatum, caffeine’s block-
ade of A1 and A2 receptor sites may  be responsible for its positive
effects in sleep-deprived individuals (Sil’kis, 2014).
To summarize, there are many occupational settings that
demand optimal physical and cognitive function to ensure suc-
cess, workplace safety and productivity. In these circumstances,
which may  include restricted overnight sleep or periods of sus-
tained wakefulness, repeated dosing of caffeine is one strategy
to maintain both physical and cognitive capabilities. The effective
dose of caffeine required to affect both physical and cognitive per-
formance is larger when the stress of additional sleep loss is present
(McLellan et al., 2004, 2005a,b, 2007). Caffeine should not be con-
sidered as a replacement for sleep if opportunities for sleep exist,
but the repeated ingestion of caffeine during overnight hours is
an effective strategy to mitigate the adverse effects of sleep loss
on physical and cognitive function (McLellan et al., 2004, 2005a,b)
and caffeine use can extend for several days if there are reduced
opportunities for sleep (McLellan et al., 2007). A summary of caf-
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Table  2
Caffeine dose (mg  kg−1 body mass) associated with cognitive and physical effects in both rested and sleep deprived individuals. The range of effective doses was obtained
from  the ﬁndings summarized in Supplementary Tables 1 through 4.
Cognitive/Physical Domain Caffeine Dose for Effect (mg kg−1)
Rested Sleep Deprived
Reaction Time 0.3–4.0 [1 h before testing] 3.0–8.5 [1 h before testing]
Vigilance 0.5–4.0 [1 h before testing] 3.0–8.5 [1 h before testing with smaller dose repeated
during period of wakefulness]
Attention 0.3–5.5 [1 h before testing] 2.5–8.0 [1 h before testing]
Acute Memory 1.0–4.0 [equivocal ﬁndings] Unknown
Chronic Effects on Memory Positive relationship between habitual use (0–10) and performance Unknown
Executive Function 0.7–5.5 [higher dose required for habitual user] 10.7 [2.7 repeated every 2 h for total 10.7/night for 3
nights]
Judgement/Risk Taking Unknown 8.0–10.7 [equivocal ﬁndings, higher doses represent
cumulative total from redosing during overnight]
Endurance Exercise 3.0–9.0 [1 h before, higher dose for users, effects last longer for
non-users]
1.5–2.5 [during or following prior exercise]
8.0 [divided unequally over 7 h to restore to control]
8.0 [divided equally over 6 h to improve over control]
Muscle  Strength/Power 3.0–6.0 [1 h before] 10.7 [2.7 repeated every 2 h for total 10.7/night for 3
nights]
High-Intensity/Sprint 3.0–10.0 [1 h before to immediately prior to exercise] 10.7 [2.7 repeated every 2 h for total 10.7/night for 3
nights]






































eexercise, independent of habitual use]
eine doses documented to exert cognitive and physical effects in
oth rested and sleep deprived individuals is shown in Table 2.
. Side-effects
Some individuals report experiencing negative side-effects of
affeine especially at high doses, such as increased levels of anx-
ety or gastrointestinal distress, possibly in part due to genetic
actors such as the presence of certain adenosine receptor poly-
orphisms (Childs et al., 2008). Such individuals often are not
egular consumers of caffeine (Yang et al., 2010) so their exces-
ive sensitivity to the drug may  reduce or eliminate its potential
ositive effects on physical and cognitive function. Individual dif-
erences in the response to a given dose of caffeine were identiﬁed
s a confounding issue in some of the earliest reports on the
rgogenic effects of the drug (Alles and Feigen, 1942; Foltz et al.,
942b; Rivers and Webber, 1907). In more recent work, partici-
ants are often asked to report any negative side-effects following
affeine ingestion and occasionally (Conway et al., 2003; Graham
nd Spriet, 1995; Spriet et al., 1992), but not always (Duvnjak-
aknich et al., 2011; Graham et al., 1998), performance has been
dversely affected among these individuals. At higher doses of
affeine, exceeding about 7 mg  kg−1 (∼500 mg), ergogenic effects
ometimes are not observed (Cadarette et al., 1982; Graham and
priet, 1995), especially among light users or non-users of the
rug (Graham and Spriet, 1995), whereas regular users can tolerate
igher doses and endurance performance is improved (Spriet et al.,
992). Adverse effects, such as tremors, nausea and nervousness
ave also been reported among light to moderate users of caf-
eine following a 600 mg  (∼ 8 mg  kg−1) dose of caffeine ingested
fter approximately 40 h of sleep deprivation (Wesensten et al.,
002, 2005). However, when similar or larger doses to 800 mg
∼10.5 mg  kg−1) caffeine were provided by a gum administered
n divided portions throughout 1–3 nights of sustained wakeful-
ess no adverse effects were noted among both nonusers and
abitual users of the drug (McLellan et al., 2005a, 2005b, 2007).
he potential long-term negative health effects of these higher
oses of caffeine, if continued for prolonged periods, is unknown
ut these doses are clearly greater than the daily limit of 400 mg
∼5.5 mg  kg−1) recommended as safe for healthy adults (Nawrot
t al., 2003) and much higher than the typical intake of the U.S.adult population (approximately 186 mg  d−1) (Fulgoni et al., 2015).
Sleep patterns may  also be adversely affected, especially if caf-
feine is ingested during exercise in the late afternoon or early
evening (Ali et al., 2015; Miller et al., 2014; Salinero et al., 2014).
Although extremely rare, very high doses of caffeine can be fatal
(Jabbar and Hanly, 2013). Caffeine can be toxic if plasma concentra-
tions of caffeine exceed 250 M (see Fig. 1). Assuming a 5 mg  kg−1
caffeine dose results in a circulating concentration between 30
and 40 M (see Fig. 3), then a 7–8 fold greater dose of caffeine
equivalent to 35–40 mg  kg−1 could be fatal. The median lethal
dose (LD50) of caffeine in various animal species approximates
200 mg  kg−1 (Dews, 1982). Since caffeinated products provide an
absolute dose for any given serving size, rather than a dose propor-
tional to body mass (see Table 1), concern has been raised about the
overuse of some products among adolescents (Wolk et al., 2012).
Furthermore, many caffeine containing products do not provide
caffeine content. In addition, the FDA recently issued warnings to
certain distributors of pure powdered caffeinated products due
to risk to consumers for overdosing (http://www.fda.gov/Food/
DietarySupplements/ProductsIngredients/ucm460095.htm).
It has been hypothesized that the positive effects of caffeine
reported in many studies may  actually reﬂect a placebo effect
(Beedie et al., 2006; Foad et al., 2008) or a rebound from the negative
symptoms experienced during the withdrawal or abstinence period
imposed by the experimental design prior to administration of the
drug (James, 1994; James et al., 2005; James and Rogers, 2005).
For some regular users of caffeine a period of abstinence for 24 h
or longer is associated with symptoms of headache and irritability
(Juliano and Grifﬁths, 2004) that might result in decreased perfor-
mance under placebo conditions of a study. These concerns should
be considered when caffeine research is designed. However, others
believe this hypothesis could not explain the behavioral effects of
caffeine observed among non-consumers (Addicott and Laurienti,
2009; Childs and deWit, 2006) and the observation that low doses
of caffeine equivalent to 1 and 2 mg  kg−1 (∼75 and 150 mg,  respec-
tively) have improved cognitive function in regular users following
an abstinence period of only 1 h (Warburton, 1995). Furthermore,
regardless of whether there is 0, 2 or 4 days of abstinence, caffeine
ingestion has similar ergogenic effects for regular users of the drug
whether they are light-to-moderate (Irwin et al., 2011) or heavy
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. Overall conclusions − cognitive and physical
erformance
This review examined the effects of caffeine on physical and cog-
itive function alone or in combination. The following conclusions
ppear justiﬁed based on the material presented:
a. Caffeine exerts its effects on cognitive and physical function
through adenosine A1 and A2a receptor blockade in the CNS and
peripheral tissues;
. Caffeine, in doses up to approximately 300 mg  (∼4 mg  kg−1),
enhances a wide array of basic cognitive functions with minimal
side effects by preventing alertness and attention decrements
associated with suboptimal arousal, consistent with the Yerkes-
Dodson inverted U-hypothesis;
c. The effects of caffeine on higher-order executive skills, com-
plex judgments, emotional discernment, and decision-making
are unclear and require further study;
. The ability of caffeine to enhance cognitive and physical func-
tion is dose-dependent. Doses of approximately 0.5–4.0 mg  kg−1
(∼40–300 mg)  can improve cognitive function in rested indi-
viduals, whereas doses of 3–7 mg  kg−1 (∼200–500 mg)  ingested
approximately 1 h prior to exercise can enhance physical per-
formance. However, response to a given dose shows large
inter-individual variation;
e. The ergogenic effects of caffeine are present across a wide
spectrum of exercise modalities including endurance tests to
exhaustion or time-trials lasting several minutes to over an
hour, tests of muscle strength and associated tests of muscu-
lar endurance, high-intensity efforts lasting longer than 60 s, or
tests of speed, power and agility during repeated high-intensity
intervals;
f. Threshold circulating plasma concentrations required to pro-
duce an ergogenic response may  be as high as 15–20 M when
caffeine is ingested prior to exercise but may  be as low as 5 M
when ingested during exercise. These threshold concentrations
appear to be lower for caffeine naïve than non-naive individuals
and the ergogenic response is present for several hours following
ingestion;
g. The use of caffeine as an ergogenic aid need not be restricted
during exposure to hot environments due to fears of increased
ﬂuid loss and rates of heat storage;
. Caffeine is an effective strategy to counter both physical and
cognitive degradation associated with sleep loss.
It is hoped that this review will stimulate conduct of addi-
ional research that examines: 1) the interplay between adenosine
eceptor genotype and its sensitivity to caffeine; 2) the behavioral
ffects of caffeine on higher order cognitive function; 3) whether
xercise alters adenosine receptor sensitivity; 4) common central
oci that can explain the dual effects of caffeine on cognitive and
hysical function; and 5) whether methods can be developed that
hange receptor sensitivity and create ‘responders’ from those who
re classiﬁed as ‘non-responders’ without an associated increase
n adverse effects that impact performance. Also when possible,
ollection of plasma or saliva samples should be included in the
xperimental designs to ensure caffeine abstinence prior to drug
ngestion and to relate circulating concentrations of the drug to the
bserved physical and cognitive effects. In addition, participants’
istory of caffeine use together with lifestyle factors that might
mpact on caffeine clearance should be clearly identiﬁed, controlled
or, and included when appropriate in the analyses of data. Simi-
arly, the inﬂuence of caffeine withdrawal and placebo expectations
n the performance metrics assessed should be addressed within
he experimental design.havioral Reviews 71 (2016) 294–312 307
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